Upstream Manufacturing Webinars
-
The Case For Optimized And Excipient GMP Cell Culture Solutions
10/27/2025
Learn how optimized, customizable formulations and Excipient GMP manufacturing streamline development, ensuring quality and consistency for a de-risked path to the clinic.
-
Smarter CMC Strategies To Accelerate Next-Gen Biologics To The Clinic
10/23/2025
Learn how process design and cross-functional collaboration mitigate risks and accelerate the path from early development to FIH manufacturing through real-world case studies of practical approaches.
-
Enhancing Non-Viral CAR T Manufacturing With Electroporation And Microbubble T Cell Isolation
10/22/2025
Unlock superior non-viral CAR T manufacturing outcomes by combining gentle microbubble T cell isolation with advanced electroporation. See how this approach boosts cell viability and transfection efficiency.
-
Game-Changing CLD Platforms: Strategies, Technologies, Workflows
10/21/2025
Selecting the right cell line platform is complex. Learn how flexible strategies, integrated technologies, and expert workflows enable high productivity, rapid timelines, and a de-risked path to clinical success.
-
Developing Antibodies To Block Neuroinflammation With MindImmune's Stevin Zorn, Ph.D.
10/20/2025
In this episode of "Better Biopharma," host Tyler Menichiello is joined by MindImmune's president and CEO, Stevin Zorn, Ph.D. They discuss the development of the company's lead candidate, MITI-101, a monoclonal antibody designed to prevent peripheral immune cells from entering the brain and driving neuroinflammation linked to Alzheimer's disease.
-
Break The Cell Therapy Manufacturing Bottleneck With Day-0 Transduction, Day-3 Harvest
10/14/2025
Discover the potential of T1 cell-derived nanoparticles (CDNPs) to accelerate T-cell activation. See how CDNPs’ unique mechanism of mimicking physiological immune stimulation positions them for broad use.
-
Cell Bank And Scale Up Strategies For MSC And Exosome Manufacturing
10/9/2025
Discover how effective cell banking and scale-up strategies can reduce risk and cost in advanced therapy manufacturing. Learn practical ways to meet increasing cell and exosome quantity needs.
-
Complex Antibody Expression - Challenge Accepted
10/2/2025
Explore how tailored cell line development strategies are enabling high-yield production of complex biologics and reveal how automation and data modeling drive success in CHO cell line development.
-
Genetically Modified MSCs For The Treatment Of GvHD
9/30/2025
Discover how genetically engineered MSCs are significantly advancing GvHD treatment. Learn about preclinical success with CXCR4-IL10-MSCs and the process for scaling up their GMP production.
-
Effective Supply Chain And QC Testing Through Collaborative Partnerships
9/30/2025
Explore how cross-functional teams streamline cell therapy manufacturing and release for Phase 1 trials to meet patient timelines and ensure safe delivery of personalized treatments.